Security key
45259L205
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 471,673
- Total 13F value
- $304,569
- Share change
- +122,210
- SEC-reported price per share
- $0.65
- Number of holders
- 17
- Value change
- +$67,747
- Number of buys
- 9
- Number of sells
- 6
Report period
Q2 2025
Institutions
17
Top holders
10
IBO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
IMPACT BIOMEDICAL INC. SEC filings
IMPACT BIOMEDICAL INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45259L205
Recent filing periods:
Ownership snapshot
Top reported holders of IBO - IMPACT BIOMEDICAL INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Chan Heng Fai Ambrose
Disclosed value leader
DSS, INC.
Comparable rows
1/15
Latest evidence
22 May 2025
13D/G
3/4/5
13F
Lead comparable stake: 2.9%
14 rows are not safely comparable across share classes.
13D/G row: Chan Heng Fai Ambrose
Showing 1-6 of 15 holder rows.
Quick read
Chan Heng Fai Ambrose leads the comparable SEC ownership view at 2.9%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Chan Heng Fai Ambrose's linked filing trail.
Comparable ownership
Top 1
Chan Heng Fai Ambrose
2.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Chan Heng Fai Ambrose |
13D/G
Heng Fai Ambrose Chan
|
2.9%
|
—
351,555 shares
|
$0 | 02 Apr 2025 |
| DSS, INC. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$294,476
545,024 shares
|
— | 22 May 2025 |
| Frank D. Heuszel |
3/4/5
Chief Executive Officer, Director
|
—
class O/S missing
|
$219,783
97,344 shares
|
— | 05 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$110,008
126,446 shares
|
— | 31 Mar 2025 |
| HRT FINANCIAL LP |
13F
Company
|
—
class O/S missing
|
$59,000
68,158 shares
|
— | 31 Mar 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$52,474
60,315 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
17
Shares
471,673
Rows available
17
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
15
Q2 2025 holders
17
Holder diff
2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend